Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease.

Noelker C, Schwake M, Balzer-Geldsetzer M, Bacher M, Popp J, Schlegel J, Eggert K, Oertel WH, Klockgether T, Dodel RC.

Neurosci Lett. 2012 Jan 17;507(1):10-5. doi: 10.1016/j.neulet.2011.11.035. Epub 2011 Dec 1.

PMID:
22155091
2.

Gender segregation in gene expression and vulnerability to oxidative stress induced injury in ventral mesencephalic cultures of dopamine neurons.

Tao Q, Fan X, Li T, Tang Y, Yang D, Le W.

J Neurosci Res. 2012 Jan;90(1):167-78. doi: 10.1002/jnr.22729. Epub 2011 Sep 14.

PMID:
21919034
3.

Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.

Wang J, Duhart HM, Xu Z, Patterson TA, Newport GD, Ali SF.

Neurochem Int. 2008 May;52(6):1037-43. Epub 2007 Nov 4.

PMID:
18069091
4.

Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.

Porritt MJ, Batchelor PE, Howells DW.

Exp Neurol. 2005 Mar;192(1):226-34.

PMID:
15698637
5.

Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.

Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S.

J Neurosci Res. 2009 Feb;87(2):576-85. doi: 10.1002/jnr.21869.

PMID:
18803299
6.

Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model.

Park B, Yang J, Yun N, Choe KM, Jin BK, Oh YJ.

Neurochem Int. 2010 Aug;57(1):16-32. doi: 10.1016/j.neuint.2010.04.005. Epub 2010 Apr 18.

PMID:
20403401
7.

Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology.

Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, Eisenhauer PB, Fine RE, Wells JM.

Brain Res. 2004 Oct 1;1022(1-2):164-72.

PMID:
15353226
8.

Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.

Lu L, Neff F, Fischer DA, Henze C, Hirsch EC, Oertel WH, Schlegel J, Hartmann A.

Neurobiol Dis. 2006 Aug;23(2):409-21. Epub 2006 Jun 6.

PMID:
16753304
9.

Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.

Ikeda Y, Tsuji S, Satoh A, Ishikura M, Shirasawa T, Shimizu T.

J Neurochem. 2008 Dec;107(6):1730-40. doi: 10.1111/j.1471-4159.2008.05743.x. Epub 2008 Nov 7.

10.

Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.

Zhang X, Andren PE, Svenningsson P.

Physiol Behav. 2007 Sep 10;92(1-2):29-33. Epub 2007 May 21.

PMID:
17588622
11.

NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease.

Crocker SJ, Wigle N, Liston P, Thompson CS, Lee CJ, Xu D, Roy S, Nicholson DW, Park DS, MacKenzie A, Korneluk RG, Robertson GS.

Eur J Neurosci. 2001 Jul;14(2):391-400.

PMID:
11553289
12.
14.

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.

Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J.

Brain Pathol. 2009 Jan;19(1):91-107. doi: 10.1111/j.1750-3639.2008.00171.x. Epub 2008 May 7.

PMID:
18462474
15.

Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.

Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.

Neuroscience. 2008 May 15;153(3):634-44. doi: 10.1016/j.neuroscience.2008.02.033. Epub 2008 Feb 29.

PMID:
18420351
16.

Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.

Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B.

FASEB J. 2004 Mar;18(3):589-91. Epub 2004 Jan 20.

PMID:
14734632
17.

The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity.

Barzilai A, Zilkha-Falb R, Daily D, Stern N, Offen D, Ziv I, Melamed E, Shirvan A.

J Neural Transm Suppl. 2000;(60):59-76.

PMID:
11205158
18.

Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.

Kim HG, Ju MS, Shim JS, Kim MC, Lee SH, Huh Y, Kim SY, Oh MS.

Br J Nutr. 2010 Jul;104(1):8-16. doi: 10.1017/S0007114510000218. Epub 2010 Feb 26.

PMID:
20187987
19.

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.

Neurobiol Dis. 2006 May;22(2):421-34. Epub 2006 Feb 9.

PMID:
16480889
20.

Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.

Nagel F, Falkenburger BH, Tönges L, Kowsky S, Pöppelmeyer C, Schulz JB, Bähr M, Dietz GP.

J Neurochem. 2008 May;105(3):853-64. doi: 10.1111/j.1471-4159.2007.05204.x. Epub 2007 Dec 24.

Supplemental Content

Support Center